Anti-Aβ globulomer 7C6 antibodies
AssigneesAbbVie Deutschland GmbH & Co. KG, AbbVie Inc.
InventorsStefan Barghorn, Heinz Hillen, Boris Labkovsky, Andreas R. Striebinger, Patrick Keller, Ulrich Ebert
Life of this patent
Estimating the term…
Loading patent…
AssigneesAbbVie Deutschland GmbH & Co. KG, AbbVie Inc.
InventorsStefan Barghorn, Heinz Hillen, Boris Labkovsky, Andreas R. Striebinger, Patrick Keller, Ulrich Ebert
Estimating the term…
Anti-Aβ globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies. The present invention relates to anti-Aβ globulomer antibodies having a binding affinity to Aβ(20-42) globulomer that is greater than the binding affinity of the antibody to Aβ(1-42) globulomer, antigen-binding moieties thereof, hybridomas producing said antibodies, nucleic acids encoding said antibodies, vectors comprising said nucleic acids, host cells comprising said vectors, methods of producing said antibodies, compositions comprising said antibodies, therapeutic and diagnostic uses of said antibodies and corresponding methods relating to Alzheimer's disease and other amyloidoses.
An antibody selected from the group consisting of an isolated antibody, a monoclonal antibody and a recombinant antibody, wherein
An antibody selected from the group consisting of an isolated antibody, a monoclonal antibody and a recombinant antibody, wherein said antibody comprises two variable domains, wherein said two variable domains are SEQ ID NO:11 and SEQ ID NO:12.
Monoclonal antibody (7C6) obtainable from a hybridoma designated by American Type Culture Collection deposit number PTA-7240.
Hybridoma designated by an American Type Culture Collection deposit number PTA-7240.
Dependencies are inferred from the claim text.